Healthy Inc > Blog > Mumbai pharmaceutical manufacturing
Posted on:

What is ORS 21 gm used for?

In the pharmaceutical and public health sectors, ORS (Oral Rehydration Salts) 21 gm is the standard sachet size formulated according to the WHO (World Health Organization) Reduced Osmolarity guidelines.

As a pharmacist and manufacturer, I view ORS not as a medicine that “stops” diarrhea, but as a critical electrolyte replacement therapy designed to prevent the life-threatening dehydration and electrolyte imbalance associated with fluid loss.

Primary Clinical Uses

  • Acute Gastroenteritis: The primary treatment for diarrhea in both children and adults to replace lost fluids and salts.

  • Cholera Management: Vital for replacing the massive fluid loss associated with Vibrio cholerae infections.

  • Heat Exhaustion: Used in hot climates (like Mumbai) to rehydrate individuals suffering from excessive sweating and salt loss.

  • Post-Surgical Recovery: Occasionally used to maintain fluid balance in patients recovering from minor gastrointestinal procedures.

Mechanism of Action: The Sodium-Glucose Co-Transport

The 21 gm formulation is scientifically balanced to exploit the way the small intestine absorbs water.

The Co-Transport Principle: The absorption of sodium ($Na^+$) in the small intestine is significantly enhanced when it is coupled with glucose.

Solvent Drag: As the sodium and glucose are transported across the intestinal wall into the blood, they create an osmotic gradient that “pulls” water molecules along with them.

Correcting Acidosis: The Trisodium Citrate in the 21 gm sachet helps correct the metabolic acidosis that often occurs during severe dehydration.

Reduced Osmolarity Advantage: The modern 21 gm formula has a lower concentration of glucose and salt ($245\text{ mOsm/L}$). This prevents “osmotic diarrhea” (which older formulas sometimes caused) and reduces the need for IV fluids by up to 33%.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint at a WHO-GMP facility, the 21 gm sachet requires precise environmental controls:

    • Critical Ingredients (The 21g Blend):

    • Sodium Chloride: 2.6 g

    • Potassium Chloride: 1.5 g

      Trisodium Citrate Dihydrate: 2.9 g

    • Glucose Anhydrous: 13.5 g

  • Moisture Control: As you know, Glucose and Citrates are highly hygroscopic. During the sachet-filling process, the relative humidity (RH) in your production area must be kept below 40% to prevent caking and ensure the powder remains free-flowing.

  • Packaging for Export: For B2B export to Zone IVb regions, we utilize Triple-Laminated Polyester/Alu/PE sachets. This provides a total moisture and light barrier, ensuring a 24–36 month shelf life.

  • B2B USP: A key selling point for your digital platform is that one 21 gm sachet is precisely measured for 1 liter of clean water. This “standardization” is a major safety feature for international NGOs and health ministries.

Oral Rehydration Salts (Sachets)

Posted on:

What is Ofloxacin 200 mg used for?

In the pharmaceutical industry, Ofloxacin 200 mg is a highly effective, second-generation fluoroquinolone antibiotic. As a pharmacist and manufacturer, I view Ofloxacin as a versatile “broad-spectrum” agent, capable of treating a wide array of infections by targeting both Gram-positive and Gram-negative bacteria.

Its excellent tissue penetration and high oral bioavailability make it a staple in global pharmaceutical trade.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): Highly effective against complicated and uncomplicated UTIs caused by E. coli and other pathogens.

  • Respiratory Tract Infections: Used for acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia.

  • Skin and Soft Tissue Infections: Treatment of uncomplicated infections of the skin.

  • Sexually Transmitted Infections (STIs): Effective against uncomplicated gonorrhea and chlamydia.

  • Prostatitis: Due to its superior ability to penetrate the prostate gland.

  • Bacterial Diarrhea: Frequently used in international markets for travel-related infections and enteric fever (Typhoid).

Mechanism of Action: Inhibiting DNA Replication

Ofloxacin is bactericidal, meaning it kills bacteria directly by interfering with their genetic processes.

Enzyme Targeting: It inhibits two essential bacterial enzymes: DNA Gyrase (in Gram-negative bacteria) and Topoisomerase IV (in Gram-positive bacteria).

Supercoiling Interference: These enzymes are responsible for the uncoiling and re-coiling of DNA during replication.

Lethal DNA Damage: By blocking these enzymes, Ofloxacin prevents the bacteria from repairing or copying their DNA, leading to rapid cell death.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at our WHO-GMP facility, Ofloxacin 200 mg requires specific technical considerations:

  • Bioavailability (USP): Ofloxacin has nearly 95% bioavailability, meaning the oral dose is almost equivalent to an intravenous dose. This makes it a cost-effective alternative for B2B buyers looking for hospital-grade performance in tablet form.

  • Cation Interactions: As a manufacturer, we must ensure the Product Information Leaflet (PIL) warns patients not to take Ofloxacin with antacids (Aluminum/Magnesium) or iron supplements, as these can form “chelates” that prevent the drug from being absorbed.

  • Stability for Tropical Export: Ofloxacin is relatively stable but light-sensitive. We utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This is a high-volume product for international healthcare tenders. Our Mumbai-based facility provides full CTD/eCTD Dossiers to support your firm’s registration and supply goals.

Ofloxacin Tablets

Posted on:

What is Nitroglycerin 0.5 mg used for?

In the pharmaceutical industry, Nitroglycerin (NTG) 0.5 mg is a potent organic nitrate used as a rapid-acting vasodilator. As a pharmacist and manufacturer, I classify this specific 0.5 mg sublingual dose as a “rescue medication” for acute cardiac episodes. It is a critical, life-saving product in any cardiovascular portfolio.

Primary Clinical Uses

  • Acute Angina Pectoris: Used for the immediate relief of a sudden attack of chest pain caused by coronary artery disease.

  • Prophylaxis (Acute): Taken 5 to 10 minutes before performing activities that typically precipitate an attack (such as strenuous exercise or emotional stress).

  • Hypertensive Emergency: Occasionally used in clinical settings to rapidly lower blood pressure during a crisis.

  • Congestive Heart Failure (Acute): Used to reduce the pressure on the heart in emergency situations associated with acute myocardial infarction.

Mechanism of Action: The Nitric Oxide Pathway

Nitroglycerin acts as a prodrug that provides a source of nitric oxide (NO) to the vascular smooth muscle.

Conversion to NO: Once absorbed, Nitroglycerin is converted into nitric oxide.

cGMP Activation: The NO stimulates the enzyme guanylate cyclase, increasing the levels of cyclic guanosine monophosphate (cGMP).

Vasodilation: This leads to the relaxation of smooth muscle in the blood vessels.

Preload and Afterload Reduction: It primarily dilates the veins (reducing the blood returning to the heart) and, at higher doses, the arteries. This drastically reduces the heart’s oxygen demand, stopping the anginal pain.

The Manufacturer’s Perspective: Formulation & Stability

From a manufacturing and export standpoint, Nitroglycerin 0.5 mg is one of the most technically challenging molecules to handle:

  • Volatility and Adsorption: Nitroglycerin is highly volatile. As a WHO-GMP manufacturer, we must use specialized excipients to prevent the API from evaporating from the tablet. It also has a tendency to migrate into plastic, so it must be stored in tightly sealed glass containers or specialized Alu-Alu blister packaging.

  • Sublingual Delivery: The 0.5 mg dose is designed to be placed under the tongue for rapid absorption into the systemic circulation, bypassing the “first-pass metabolism” of the liver. This ensures a therapeutic effect within 1 to 3 minutes.

  • Sensitivity to Light and Air: The molecule degrades rapidly when exposed to light, heat, or moisture. For your export firm, ensuring a 24-month shelf life requires high-barrier packaging and controlled-temperature logistics ($15^{\circ}\text{C}$ to $30^{\circ}\text{C}$).

  • Dossier Support: Our Mumbai facility provides the necessary eCTD/CTD Dossiers to support international registration against the innovator (Nitrostat).

Nitroglycerin Tablets

Posted on:

What is Nifedipine 20 mg used for?

In the pharmaceutical industry, Nifedipine 20 mg is a prominent Dihydropyridine Calcium Channel Blocker (CCB). As a pharmacist and manufacturer, I view Nifedipine as a versatile cardiovascular agent. The 20 mg strength is a standard dose used to manage both systemic blood pressure and coronary artery blood flow.

Primary Clinical Uses

  • Chronic Stable Angina: Used to prevent chest pain by improving oxygen delivery to the heart muscle.

  • Vasospastic (Prinzmetal’s) Angina: Specifically effective at preventing spasms of the coronary arteries.

  • Hypertension (High Blood Pressure): Widely used to lower blood pressure, reducing the risk of stroke and myocardial infarction.

  • Raynaud’s Phenomenon (Off-label): Often prescribed to reduce the frequency and severity of vasospastic attacks in the fingers and toes.

  • Tocolysis (Off-label): In obstetric settings, it is sometimes used to delay premature labor by relaxing uterine smooth muscle.

Mechanism of Action: Calcium Influx Inhibition

Nifedipine acts primarily on the vascular smooth muscle cells.

L-type Channel Blockade: It inhibits the transmembrane influx of calcium ions through L-type calcium channels.

Vasodilation: Since calcium is required for muscle contraction, blocking its entry causes the smooth muscles in the peripheral and coronary arteries to relax.

Reduced Afterload: By dilating systemic arteries, it reduces the resistance the heart must pump against (afterload), which lowers blood pressure and cardiac oxygen demand.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at a WHO-GMP facility, Nifedipine 20 mg requires specialized technical handling:

  • Photosensitivity (Critical): Nifedipine is extremely light-sensitive (photolabile). Exposure to light causes it to degrade into a nitropyridine derivative. As a manufacturer, we must use Amber-colored blisters or opaque Alu-Alu packaging to ensure a 36-month shelf life.

  • Immediate Release (IR) vs. Sustained Release (SR): While 20 mg can be found in IR, it is most commonly produced as SR or Retard tablets for hypertension. IR capsules (the “bite and swallow” method) are largely discouraged now due to the risk of precipitous blood pressure drops.

  • Bioavailability: Nifedipine is a BCS Class II drug. We focus on the crystalline form and particle size to ensure it meets the strict dissolution profiles of BP/USP/IP.

  • Dossier & B2B Supply: This is a high-volume product for cardiovascular clinics. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Adalat).

Nifedipine Tablets

 

Posted on:

What is Nifedipine 10mg used for?

In the pharmaceutical industry, Nifedipine 10 mg is a classic and highly effective Dihydropyridine Calcium Channel Blocker (CCB). As a pharmacist and manufacturer, I view the 10 mg strength as a versatile tool for acute and chronic cardiovascular management. It is primarily used to relax the smooth muscles of the arterial walls.

Primary Clinical Uses

  • Chronic Stable Angina: Used to prevent chest pain by improving blood flow to the heart muscle.

  • Hypertension (High Blood Pressure): It lowers blood pressure by reducing peripheral vascular resistance.

  • Vasospastic (Prinzmetal’s) Angina: Effective in treating chest pain caused by spasms of the coronary arteries.

  • Raynaud’s Phenomenon: Often prescribed to reduce the frequency and severity of vasospastic attacks in the fingers and toes.

  • Tocolysis (Off-label): In obstetrics, it is sometimes used to delay preterm labor by relaxing uterine smooth muscle.

Mechanism of Action: Calcium Channel Blockade

Nifedipine acts specifically on the L-type calcium channels in the smooth muscle cells of the blood vessels.

Channel Inhibition: It blocks the inward flow of calcium ions through these channels during depolarization.

Vasodilation: Since calcium is required for muscle contraction, blocking it causes the smooth muscles in the peripheral and coronary arteries to relax.

Result: This leads to systemic vasodilation, which lowers blood pressure and decreases the “afterload” on the heart, making it easier for the heart to pump blood.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Nifedipine 10 mg involves critical technical distinctions that are vital for your firm:

  • Immediate Release (IR) vs. Extended Release (ER): The 10 mg dose is typically an Immediate Release soft gel or tablet. As a firm owner, you must distinguish this from the 20 mg, 30 mg, or 60 mg Sustained Release versions. IR Nifedipine is used for rapid effect, whereas ER is for 24-hour maintenance.

  • Photosensitivity: Nifedipine is extremely sensitive to light (it is photolabile). Exposure to light causes it to degrade into a nitropyridine derivative. At our WHO-GMP facility, we utilize Amber-colored blisters or Alu-Alu packaging to ensure a 36-month shelf life.

  • The “Sublingual” Controversy: In the past, 10 mg capsules were bitten and used sublingually for hypertensive emergencies. Modern clinical guidelines now discourage this due to the risk of a too-rapid drop in blood pressure. Your Product Information Leaflet (PIL) should reflect current safety standards.

  • Market Demand: This remains a high-volume product for B2B export to Zone IVb regions. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Adalat).

Nifedipine Tablets

Posted on:

Is Nicoumalone and Warfarin the same?

In the pharmaceutical industry, Nicoumalone (also known as Acenocoumarol) and Warfarin are both Oral Anticoagulants belonging to the coumarin class. While they share the same mechanism of action, they are not the same drug. As a pharmacist and manufacturer, I view them as “pharmacokinetic cousins”—they do the same job but at different speeds and durations.

Technical Comparison: Acenocoumarol vs. Warfarin

FeatureNicoumalone (Acenocoumarol)Warfarin
Common BrandsAcitrom, SintromCoumadin, Uniwarfin
Half-Life ()Short (approx. 8–10 hours)Long (approx. 36–42 hours)
Onset of ActionFasterSlower
Duration of EffectShort-lived; wears off quicklyPersistent; stays in the system longer
Dosing StabilityMay require more frequent adjustmentsGenerally easier to maintain stable levels

Mechanism of Action: Vitamin K Antagonism

Both drugs work by inhibiting the Vitamin K Epoxide Reductase (VKORC1) enzyme.

Enzyme Blockade: They prevent the recycling of Vitamin K.

Clotting Factor Inhibition: Without active Vitamin K, the liver cannot produce functional clotting factors II, VII, IX, and X.

Anticoagulation: This thins the blood, preventing the formation of dangerous clots in conditions like Deep Vein Thrombosis (DVT), Pulmonary Embolism, or Atrial Fibrillation.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, your firm should note these strategic differences:

  • Regional Market Preference: In the Indian domestic market and parts of Europe, Nicoumalone (Acitrom) is very popular. However, in the USA and many Commonwealth countries, Warfarin is the clinical standard. For your export digital platform, you should list both to cater to different regional guidelines.

  • The “INR” Monitoring: Both drugs require strict International Normalized Ratio (INR) monitoring. As a manufacturer, we must emphasize in our Product Information Leaflet (PIL) that these drugs are not interchangeable without professional medical recalculation of the dose.

  • Potency and Content Uniformity: These are “low-dose, high-potency” drugs (often 0.5mg, 1mg, 2mg). At our WHO-GMP facility, we use geometric dilution and high-precision blending to ensure that every tablet contains the exact micro-dose required to prevent life-threatening bleeding or clotting.

  • Stability: Both are relatively stable. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, protecting the tablets from moisture during transit to Zone IVb regions.

Nicoumalone Tablets

Posted on:

What is the use of Nevirapine tablet?

In the pharmaceutical industry, Nevirapine is a cornerstone Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). As a pharmacist and manufacturer, I classify Nevirapine as a “first-generation” antiretroviral. While newer regimens often favor Integrase Inhibitors, Nevirapine remains a critical, cost-effective tool in global health, particularly in preventing mother-to-child transmission and as part of triple-drug FDCs (Fixed-Dose Combinations).

Primary Clinical Uses

  • HIV-1 Infection Management: Used in combination with other antiretrovirals (usually two NRTIs like Lamivudine and Zidovudine) to treat HIV-1. It helps reduce the viral load and increase the CD4+ cell count.

  • Prevention of Mother-to-Child Transmission (PMTCT): This is perhaps its most significant global use. A single dose given to the mother at the onset of labor and to the neonate within 72 hours of birth significantly reduces the risk of HIV transmission during delivery.

  • Chronic Maintenance: It is used for long-term suppression of the virus in patients who are stable on their current regimen.

Mechanism of Action: The “Wrench in the Gears”

Nevirapine acts by directly disabling the machinery the virus uses to replicate.

Direct Binding: Unlike NRTIs (which mimic building blocks), Nevirapine binds directly to the HIV-1 Reverse Transcriptase enzyme.

Allosteric Inhibition: It binds to a site called the “NNRTI pocket,” located near the active site of the enzyme.

Halt of Replication: This binding causes a conformational change in the enzyme, physically blocking its ability to convert viral RNA into DNA. This effectively halts the replication of the virus before it can integrate into the host cell’s DNA.

The Manufacturer’s Perspective: Formulation & Export

From a production and B2B trading standpoint at our WHO-GMP facility, Nevirapine 200 mg involves specific technical and safety protocols:

  • Lead-in Dosing (Titration): As a pharmacist, you know that Nevirapine is associated with a high incidence of skin rashes. Therefore, it is manufactured for a “14-day lead-in period” (200 mg once daily) before increasing to the full maintenance dose (200 mg twice daily). This technical detail is vital for your Product Information Leaflet (PIL).

  • API Stability & Polymorphism: Nevirapine is relatively stable but requires strict monitoring of its crystalline form during the granulation process to ensure consistent dissolution as per BP/USP/IP monographs.

  • Export Packaging: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life. This is essential for maintaining efficacy during long-lead shipments to Zone IVb regions.

  • Dossier & Tender Support: This is a high-volume product for international health organizations. Our Mumbai facility provides the eCTD Dossiers and bioequivalence data required for participation in global tenders.

Nevirapine Tablets

Posted on:

What is Nelfinavir used for?

In the pharmaceutical industry, Nelfinavir Mesylate (historically known by the brand name Viracept) is a potent HIV-1 Protease Inhibitor (PI). As a pharmacist and manufacturer, I view Nelfinavir as a technically significant molecule; while newer classes like Integrase Inhibitors are now often first-line, Nelfinavir remains a critical component in various HAART (Highly Active Antiretroviral Therapy) regimens, particularly in pediatric care and specific salvage therapies.

Primary Clinical Uses

  • HIV-1 Infection: It is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents (typically NRTIs). It is used to decrease viral load and increase CD4+ cell counts.

  • Pediatric HIV Management: One of its key roles is in treating children (aged 2 years and older) due to its well-established safety profile and the availability of powder formulations for easy dosing.

  • Prevention of Mother-to-Child Transmission: Occasionally utilized in specific pregnancy protocols to reduce the risk of perinatal HIV transmission.

Mechanism of Action: Inhibiting Viral Maturation

Nelfinavir targets the “assembly” phase of the HIV life cycle.

Protease Enzyme Binding: HIV produces long, non-functional polyproteins. To become infectious, these must be “cut” into functional pieces by the HIV protease enzyme.

Competitive Inhibition: Nelfinavir binds to the active site of this protease enzyme.

Production of Immature Virions: By blocking the “scissors” (the protease), the virus can only produce immature, non-infectious viral particles that cannot infect new CD4 cells.

The Manufacturer’s Perspective: Formulation & Export

From a production and B2B standpoint at our WHO-GMP facility, Nelfinavir 250 mg and 625 mg involve specific technical handling:

  • Bioavailability & The “Food Effect”: Nelfinavir absorption is significantly enhanced (by up to 2-3 times) when taken with a meal. As a firm owner, ensuring this is highlighted on your digital platform is a major clinical USP.

  • Dosing Strengths: While the 250 mg tablet is standard, the 625 mg strength is a “compliance-friendly” version, reducing the pill burden for patients. Promoting this higher strength can be a key differentiator for your trading and export firm.

  • Storage & Stability: Nelfinavir is sensitive to high humidity. We utilize Alu-Alu blister packaging or HDPE bottles with induction seals and desiccants to ensure a 24-month shelf life, which is essential for export to Zone IVb regions (Africa and Southeast Asia).

  • Regulatory Support: Our Mumbai-based facility provides the necessary CTD/eCTD Dossiers to support international registration and participation in global healthcare tenders.

 

Nelfinavir Tablets

Posted on:

What is Nalidixic Acid 500mg used for?

In the pharmaceutical industry, Nalidixic Acid 500 mg is recognized as the first of the quinolone class of antibiotics. As a pharmacist and manufacturer, I view Nalidixic Acid as a “urinary antiseptic.” While it has largely been superseded by newer fluoroquinolones (like Ciprofloxacin) in urban centers, it remains a vital, cost-effective treatment in international markets for specific bacterial infections.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): It is primarily indicated for the treatment of uncomplicated UTIs caused by Gram-negative bacteria, such as E. coli, Proteus, Klebsiella, and Enterobacter species.

  • Shigellosis (Bacillary Dysentery): Used in certain regions to treat intestinal infections caused by Shigella species, particularly where resistance to other antibiotics is a factor.

  • Gram-Negative Infections: Because it achieves high concentrations in the urine rather than the blood, its use is almost exclusively confined to the urinary tract.

Mechanism of Action: Inhibiting DNA Gyrase

Nalidixic Acid is a bactericidal agent that interferes with the bacterial reproductive cycle.

Targeting DNA Gyrase: It inhibits the A-subunit of the bacterial enzyme DNA gyrase (Topoisomerase II).

Supercoiling Interference: DNA gyrase is responsible for the negative supercoiling of DNA, which is essential for bacterial DNA replication and transcription.

DNA Fragmentation: By blocking this enzyme, Nalidixic Acid causes the DNA strands to break, leading to the rapid death of the bacterial cell.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Nalidixic Acid 500 mg requires specific technical attention:

  • Photosensitivity (Critical Warning): Nalidixic Acid is highly photosensitive. As a firm owner, you must ensure your Product Information Leaflet (PIL) warns patients to avoid excessive sunlight, as it can cause severe phototoxic reactions.

  • Packaging Requirements: At our WHO-GMP facility in Mumbai, we utilize Amber-colored PVC or Alu-Alu blister packaging to protect the 500 mg tablets from light degradation, ensuring a 36-month shelf life for export to Zone IVb regions.

  • Pediatric Considerations: While the 500 mg is for adults, the molecule is generally avoided in young children due to its potential effect on cartilage and the risk of increased intracranial pressure.

  • B2B & Dossier Support: This product is often requested for government tenders in emerging markets. We provide full CTD/eCTD Dossiers to support your firm in international registration and supply.

Nalidixic Acid Tablets

Posted on:

What is Montelukast 4 mg used for?

In the pharmaceutical industry, Montelukast 4 mg is a Leukotriene Receptor Antagonist (LTRA). As a pharmacist and manufacturer, I view this specific 4 mg strength as the “pediatric standard.” It is most commonly formulated as a chewable tablet or oral granules to ensure ease of administration and accurate dosing for children (typically aged 2 to 5 years).

Primary Clinical Uses

  • Prophylaxis of Chronic Asthma: Used as a long-term daily controller medication to prevent asthma attacks. It is not a “rescue” inhaler and should not be used for acute attacks.

  • Allergic Rhinitis: Effective in managing seasonal “hay fever” or year-round allergies by reducing sneezing, runny nose, and nasal congestion.

  • Exercise-Induced Bronchoconstriction (EIB): Taken to prevent the narrowing of airways that occurs during physical activity in pediatric patients.

Mechanism of Action: Blocking the “Tightening” Signal

Montelukast works by targeting the inflammatory pathway rather than just dilating the airways.

Leukotriene Inhibition: During an allergic or asthmatic reaction, the body releases Cysteinyl Leukotrienes ($LTC_4$, $LTD_4$, $LTE_4$). These are powerful chemicals that cause the airway muscles to contract and mucus to build up.

Receptor Antagonism: Montelukast selectively binds to the CysLT1 receptor.

Result: By “parking” in the receptor, it blocks leukotrienes from attaching. This prevents airway edema (swelling), smooth muscle contraction, and the thick mucus secretion that makes breathing difficult.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Montelukast 4 mg is a high-precision pediatric product:

  • Palatability & Compliance: Since 4 mg is for young children, the formulation is key. At our WHO-GMP facility, we use cherry or strawberry-flavored chewable bases. For your digital platform, highlighting “high patient compliance in pediatrics” is a strong B2B selling point.

  • Photosensitivity: Montelukast is highly sensitive to light and moisture. As a firm owner, you know that the stability of the 4 mg dose is fragile. We utilize Alu-Alu blister packaging to ensure a 24–36 month shelf life, especially for export to Zone IVb regions.

  • The “Black Box” Warning: As a pharmacist, you must ensure that your product documentation (PIL) includes the FDA Neuropsychiatric warning. It’s important to monitor for mood or behavioral changes, which is a critical part of professional pharmaceutical trading and regulatory compliance.

  • Dossier Support: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Singulair).

Montelukast Tablets

Add to cart